𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines

✍ Scribed by Jane E. Libbey; Robert S. Fujinami

Book ID
116963050
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
212 KB
Volume
29
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

FK506 as an adjuvant of tolerogenic DNA
FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis
✍ Youmin Kang; Jia Zhao; Yue Liu; Aoshuang Chen; Guoxing Zheng; Yang Yu; Jianjie M πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 297 KB

## Abstract ## Background DNA vaccination is a strategy that has been developed primarily to elicit protective immunity against infection and cancer. ## Methods DNA vaccine was used, in conjunction with an immunosuppressant, to tolerize harmful autoimmunity. ## Results Immunization of C57BL/6

Antigen, host and adjuvant requirements
Antigen, host and adjuvant requirements for induction of hyperacute experimental autoimmune encephalomyelitis
✍ Vanda A. Lennon; F. C. Westall; Millie Thompson; Elsie Ward πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 848 KB

## Abstract A hyperacute form of experimental autoimmune encephalomyelitis (HEAE) was induced in Lewis rats using small doses (3.2 ΞΌg) of guinea pig myelin basic protein as immunogen and __B. pertussis__ vaccine as adjuvant. Myelin basic proteins from species other than guinea pig (rat, man, monkey

Murine complement C4 is not required for
Murine complement C4 is not required for experimental autoimmune encephalomyelitis
✍ Laura A. Boos; Alexander J. Szalai; Scott R. Barnum πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 59 KB

## Abstract In vitro studies have demonstrated that myelin and myelin‐derived proteins activate both the classical and alternative complement pathways. More recently, studies have shown that mice deficient in factor B, a protein required for activation of the alternative pathway, have attenuated ex

Validation of a novel biomarker for acut
Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis
✍ Melissa M. Gresle; Gerry Shaw; Bevyn Jarrott; Estella N. Alexandrou; Anna Friedh πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 257 KB

## Abstract In multiple sclerosis, inflammatory axonal injury is a key pathological mechanism responsible for the development of progressive neurological dysfunction. The injured axon represents a therapeutic target in this disease; however, therapeutic trials of neuroprotective candidates will ini